You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Oxytetracycline hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for oxytetracycline hydrochloride and what is the scope of patent protection?

Oxytetracycline hydrochloride is the generic ingredient in six branded drugs marketed by Ferrante, Hikma, Impax Labs, Proter, Purepac Pharm, Pfizer, and Casper Pharma Llc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxytetracycline hydrochloride.

Summary for oxytetracycline hydrochloride
Recent Clinical Trials for oxytetracycline hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OsloN/A
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all oxytetracycline hydrochloride clinical trials

US Patents and Regulatory Information for oxytetracycline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Proter OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060869-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Purepac Pharm OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060634-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ferrante OXY-KESSO-TETRA oxytetracycline hydrochloride CAPSULE;ORAL 060179-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Pfizer TERRAMYCIN oxytetracycline hydrochloride CAPSULE;ORAL 050286-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Pfizer TERRAMYCIN oxytetracycline hydrochloride INJECTABLE;INJECTION 060586-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Oxytetracycline hydrochloride Market Analysis and Financial Projection Experimental

Oxytetracycline Hydrochloride Market Dynamics and Financial Trajectory

Market Overview

The oxytetracycline hydrochloride market is poised for significant growth, driven by increasing demand in both human healthcare and animal husbandry. Here’s a detailed look at the market dynamics and financial trajectory of this essential antibiotic.

Market Size and Growth

The global oxytetracycline hydrochloride market was valued at approximately USD 2.1 billion in 2023 and is projected to reach around USD 3.5 billion by 2032, indicating a robust growth trajectory[3].

Compound Annual Growth Rate (CAGR)

The market is expected to grow with a CAGR of 6.5% from 2024 to 2030, reflecting the steady and consistent demand for this antibiotic[1].

Drivers of Growth

Several factors are driving the growth of the oxytetracycline hydrochloride market:

Increasing Demand in Aquaculture and Human Healthcare

The growing demand for oxytetracycline hydrochloride in aquaculture and human healthcare sectors is a major driver. This antibiotic is widely used to treat various bacterial infections and as an antibiotic growth promoter in animal breeding programs[1][2].

Expanding Applications

Oxytetracycline hydrochloride is used in various forms, including capsules, tablets, and injections, catering to different medical and veterinary needs. The pharmaceutical grade of oxytetracycline hydrochloride is expected to witness the highest growth due to its widespread application in treating a range of bacterial infections and other medical conditions[1].

Regional Analysis

The market is segmented into several regions, with Asia Pacific (APAC) expected to witness the highest growth over the forecast period.

APAC Market Growth

The APAC region is driven by growing demand for livestock and poultry products, along with rising government spending on healthcare development. This region is anticipated to be a key contributor to the overall market growth[1].

Competitive Landscape

The competitive landscape of the oxytetracycline hydrochloride market is characterized by several key players:

Major Players and Strategies

Companies in this market compete based on product quality, manufacturing capacity, R&D investments, and infrastructural development. Major players focus on expanding their manufacturing facilities, leveraging integration opportunities across the value chain, and developing innovative products and technologies to reduce production costs and expand their customer base[1].

Market Segmentation

The market is segmented by type, application, end use, and region.

Type Segmentation

The market includes various types such as oxytetracycline hydrochloride capsules, tablets, and injections. The capsule segment is expected to remain the largest due to its growing demand among patients for its anti-inflammatory and antibacterial qualities[1].

Application Segmentation

Oxytetracycline hydrochloride is used in human healthcare and veterinary applications. Its use in treating diseases such as sinusitis, bronchitis, cholera, acne, urinary tract infections, and others is significant[2].

Pricing Trends

The pricing of oxytetracycline hydrochloride has seen fluctuations due to supply and demand dynamics.

Price Volatility

In recent times, the price of oxytetracycline hydrochloride has fallen in the United States due to ample supply and weak demand. The market momentum has continued to deteriorate due to the erratic supply and demand relationship[5].

Environmental and Health Concerns

The use of oxytetracycline hydrochloride raises several environmental and health concerns.

Environmental Impact

Antibiotics like oxytetracycline can enter aquatic environments through industrial wastewater and sewage treatment plants, which have limited ability to remove these drugs. This has led to studies on adsorption processes to remove oxytetracycline from aqueous media, such as using metal-organic frameworks like ZIF-8[2].

Health Concerns

A significant fraction of oxytetracycline is not absorbed by animals and is excreted unaltered, raising concerns about antibiotic resistance and environmental pollution. The human body absorbs 60 to 80% of oxytetracycline, but its extensive use in agriculture and animal breeding programs necessitates careful management to avoid adverse health and environmental impacts[2].

Strategic Analysis

The market's competitive intensity can be analyzed using Porter's Five Forces model, which includes the threat of new entrants, the threat of substitute products, the bargaining power of buyers, the bargaining power of suppliers, and the intensity of rivalry among competitors.

Mergers and Acquisitions

Companies in the oxytetracycline hydrochloride market often engage in mergers and acquisitions to expand their market share, enhance product portfolios, and improve their competitive position[1].

New Product Development

Investments in R&D are crucial for developing innovative products and technologies. Companies focus on reducing production costs and expanding their customer base through new product development and technological advancements[1].

Key Takeaways

  • The global oxytetracycline hydrochloride market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
  • The market is driven by growing demand in aquaculture and human healthcare sectors.
  • APAC is expected to witness the highest growth due to increasing demand for livestock and poultry products and rising government spending on healthcare.
  • The pharmaceutical grade of oxytetracycline hydrochloride is expected to see the highest growth.
  • Environmental and health concerns related to the use of oxytetracycline hydrochloride necessitate careful management.

FAQs

What is the expected CAGR of the global oxytetracycline hydrochloride market from 2024 to 2030?

The global oxytetracycline hydrochloride market is expected to grow with a CAGR of 6.5% from 2024 to 2030[1].

Which region is expected to witness the highest growth in the oxytetracycline hydrochloride market?

Asia Pacific (APAC) is expected to witness the highest growth over the forecast period due to growing demand for livestock and poultry products and rising government spending on healthcare development[1].

What are the major drivers for the oxytetracycline hydrochloride market?

The major drivers for this market are the growing demand for oxytetracycline hydrochloride in aquaculture and human healthcare sectors[1].

How is oxytetracycline hydrochloride used in different applications?

Oxytetracycline hydrochloride is used in various forms such as capsules, tablets, and injections, and is applied in human healthcare and veterinary medicine to treat a range of bacterial infections[1][2].

What are the environmental concerns associated with oxytetracycline hydrochloride?

Oxytetracycline hydrochloride can enter aquatic environments through industrial wastewater and sewage treatment plants, contributing to environmental pollution and the potential for antibiotic resistance[2].

Sources

  1. Lucintel, "Oxytetracycline Hydrochloride Market Report: Trends, Forecast and Competitive Analysis," Lucintel.
  2. dos Santos Ferreira da Silva J, López Malo D, Anceski Bataglion G, Nogueira Eberlin M, Machado Ronconi C, Alves Júnior S, et al., "Adsorption in a Fixed-Bed Column and Stability of the Antibiotic Oxytetracycline Supported on Zn(II)-[2-Methylimidazolate] Frameworks in Aqueous Media," PLoS ONE 10(6): e0128436.
  3. Dataintelo, "Oxytetracycline Hcl Market Research Report 2032," Dataintelo.
  4. MarketResearchIntellect, "Oxytetracycline Tablets Market Size, Scope And Forecast Report," MarketResearchIntellect.
  5. ChemAnalyst, "Oxytetracycline Hydrochloride Price, News, Monitor," ChemAnalyst.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.